Close

Cantor Fitzgerald Starts Abeona Therapeutics (ABEO) at Buy, $21 PT

September 7, 2016 4:10 PM EDT Send to a Friend
Cantor Fitzgerald initiates coverage on Abeona Therapeutics (NASDAQ: ABEO) with a Buy rating and a price target of $21.00.Analyst Elemer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login